<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D70072C9-74EF-4652-9C2F-053E5F9006DD"><gtr:id>D70072C9-74EF-4652-9C2F-053E5F9006DD</gtr:id><gtr:name>Alzheimer Scotland</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Clinical Brain Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D70072C9-74EF-4652-9C2F-053E5F9006DD"><gtr:id>D70072C9-74EF-4652-9C2F-053E5F9006DD</gtr:id><gtr:name>Alzheimer Scotland</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DD8B3DAF-9249-4B54-9039-27C523F04D72"><gtr:id>DD8B3DAF-9249-4B54-9039-27C523F04D72</gtr:id><gtr:firstName>Donald</gtr:firstName><gtr:surname>MacIntyre</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9"><gtr:id>23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL016400%2F1"><gtr:id>6AC99D97-473D-48C0-9F10-A8EEC3F43340</gtr:id><gtr:title>MRC Brain Banks: Joint Application to Underpin Neuroscience Research</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L016400/1</gtr:grantReference><gtr:abstractText>This application plans to support research into the causes and potential treatment of a range of diseases affecting the
brain, some of which have been identified as priorities for research, such as dementia. The UK has a network of
established Brain Banks that provide human tissue samples to a wide range of researchers. Human tissue samples have
allowed a better understanding of the mechanisms operating in these complex disorders and have already aided the
development of treatments for Alzheimer's disease and Parkinson's disease.
This application will support four Brain Banks in Edinburgh, London, Newcastle and Oxford. These banks each have areas
of particular interest, Parkinson's disease, Alzheimer's disease and motor neurone disease. However, in addition to the
collection of tissues samples from patients with brain disorders, it is also essential to collect normal tissue samples for use
as controls in research. Two of the Banks have a major focus in this area, so this application will support the collection of
both disease and normal tissue samples.
The banks will support scientific research by providing human tissue samples in an efficient and cost effective manner,
while ensuring the samples provided are of the high quality required by researchers. The banks have worked to improve
their efficiency, reducing the time required to provide the samples to researchers. Details of the samples available in each
of the banks are included in a database, which is accessible through the internet. This allows researchers to see what
samples are available and how to request these samples for their research in an easy way that will save time and speed up
progress.
All four Brain Banks in this application have approval form an Ethics Committee, to ensure that their working practices meet
nationally agreed standards that apply to work with human tissue samples. The work of each Bank is overseen by a local
steering committee that includes members of the public and ethics experts as well as scientists and pathologists. Brain
Banking is expensive, but the operating costs of these four banks are far less than their equivalents in Europe and in the
USA.
The challenges of developing treatments for complex diseases such as Alzheimer's disease and Parkinson's disease are
considerable, but the Brain Banks in this application will play an important role in underpinning the scientific research in these 
national priority areas.</gtr:abstractText><gtr:technicalSummary>This joint application from the MRC Brain Banks in Edinburgh, London, Newcastle and Oxford is submitted in accordance
with the wishes of the MRC Neuroscience and Mental Health Board (NMHB). After the last funding round for the MRC
Brain Banks in 2011, NMHB indicated that a future joint application would be preferred and that the applicants should
demonstrate progress in efficiency and improving standards of work in accordance with an agreed set of metrics. This
application fulfils this request, and aims to underpin neuroscience research in the UK by providing high-quality human brain
tissue samples and data in the formats required by researchers in both academic and industrial settings. The four banks in
this application together cover the collection of human tissue samples from a range of major neurological diseases, and
normal tissue samples to act as controls. This provides an invaluable resource to underpin neuroscience research in UK,
particularly in recently identified priority areas such as dementia.
The banks have demonstrated in this application that they can work to the standards set in the metrics agreed with the
NMHB, and have improved their efficiency of operations. The banks already support a number of major researchers in
academia and industry in UK and overseas, including several who are currently funded by MRC. The provision of high
quality tissue samples and accompanying data is essential for the success of these projects; the MRC brain banks
constitute a critical infrastructure for this research.
In order to develop this important work further, funding for a 5 year period is requested; earlier funding awards for periods
of 2 years has not been conducive to long term planning and strategy. The costs of brain banking in the UK compare very
favourably with those in Europe and in the USA; over the next 5 years the banks will continue to work to improve efficiency
of operation and to operate a cost recovery programme.</gtr:technicalSummary><gtr:potentialImpactText>The activities of the brain banks will be of major significance to neuroscience researchers in the UK and the banks plan to
capitalise upon this by promoting the availability of their tissue samples during the course of this grant, primarily by the
MRC database, which will give details of all samples currently available, including control samples. This promotion will not
be confined to academic researchers, but also through the Association of British Pharmaceutical Industries the applicants
will promote the availability of the tissue samples in their banks and will engage with both academic and industrial
researchers to help provide the samples they require.
The brain banks already supply tissue samples to commercial companies for their research and development purposes and
it is planned to continue and develop these contacts within an appropriate framework.
The applicants are involved in a number of local, national and international committees and bodies that relate to research.
Policymakers within both government (DH) and non-governmental organisations and regulators (e.g. the Human Tissue
Authority) will benefit from information arising from the use of human brain tissue samples and also from the general
promotion of brain donation in neuroscience research.
The applicants have previously engaged with museums (including the Wellcome Trust museum) and charities including the
Alzheimer's Society, Alzheimer's Research UK, the Multiple Sclerosis Society and Parkinson's UK to provide expert advice
on brain banking. The applicants also work within the committee structure of these charities to advise on their research
activities, particularly those that might involve the collection and use of human tissue samples.
The wider public is likely to benefit from this planned research, particularly if the tissue samples provided result in improved
diagnosis or treatment for patients with neurodegenerative disorders. Furthermore, the promotion of brain banking and the
value of brain donation for research will help raise public awareness of the challenges of dementia and neurodegenerative
diseases, and help make individuals take an informed choice on this complex matter.
It is likely that the government may benefit from this research, particularly in respect to the activities of the Ministerial Action
Group on Dementia Research and the Prime Minister's Challenge on dementia, within which brain banking is
acknowledged as an essential requirement to support researchers in this field. The support requested in this application
will be of wider benefit to these government initiatives and the research arising from this work, supported by other
government funded bodies including NIHR.
Finally, MRC is likely to benefit from this research, since the applicants already provide large numbers of tissue samples to
researchers such as Professor John Hardy, UCL, who are in receipt of significant funding from MRC to undertake research
projects that are critically dependent on a continuous supply of high quality tissue samples that will be collected and made
available during the course of this proposal.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1397325</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuropathology</gtr:department><gtr:description>UK Brain Bank Network</gtr:description><gtr:id>6D89BF4D-B92F-4F91-9052-E5F064EE8A54</gtr:id><gtr:impact>National brain bank database allowing researchers to access a wide range of brain regions from brain disorders</gtr:impact><gtr:outcomeId>AQFuiZQkQFQ-1</gtr:outcomeId><gtr:partnerContribution>Standardisation of protocols and diagnostic procedures</gtr:partnerContribution><gtr:piContribution>All four centres have collaborated to develop a unified approach to human brain banking covering a range of human brain disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Neuropathology</gtr:department><gtr:description>UK Brain Bank Network</gtr:description><gtr:id>902D9433-30C2-45FB-B40A-6BEE748D3544</gtr:id><gtr:impact>National brain bank database allowing researchers to access a wide range of brain regions from brain disorders</gtr:impact><gtr:outcomeId>AQFuiZQkQFQ-3</gtr:outcomeId><gtr:partnerContribution>Standardisation of protocols and diagnostic procedures</gtr:partnerContribution><gtr:piContribution>All four centres have collaborated to develop a unified approach to human brain banking covering a range of human brain disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Key provider of human tissue to genome profiling group</gtr:description><gtr:id>C9F1DA34-A3A9-4268-ABAA-470B4DA3B07B</gtr:id><gtr:impact>A number of publications have been submitted.</gtr:impact><gtr:outcomeId>P6S21z3cydj-1</gtr:outcomeId><gtr:partnerContribution>Has helped develop a more robust standardised sampling protocol for brain examination and storage.</gtr:partnerContribution><gtr:piContribution>Supply of age matched control human brain tissue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alzheimer Scotland</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Developing brain bank for Alzheimer Scotland</gtr:description><gtr:id>C312C548-3A0B-4B09-99AA-A01EFCEAB26F</gtr:id><gtr:impact>None at this stage</gtr:impact><gtr:outcomeId>GirH4aq9tG3-1</gtr:outcomeId><gtr:partnerContribution>Alzheimer Scotland fund the clinical cohort and provide funding for a brain bank technician</gtr:partnerContribution><gtr:piContribution>We have brought the brain bank infrastructure to support brain banking around a well defined dementia cohort, on a national basis.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Neuroscience Newcastle</gtr:department><gtr:description>UK Brain Bank Network</gtr:description><gtr:id>032CD7AE-D34B-4A33-817C-CD0FCC9D0B4A</gtr:id><gtr:impact>National brain bank database allowing researchers to access a wide range of brain regions from brain disorders</gtr:impact><gtr:outcomeId>AQFuiZQkQFQ-2</gtr:outcomeId><gtr:partnerContribution>Standardisation of protocols and diagnostic procedures</gtr:partnerContribution><gtr:piContribution>All four centres have collaborated to develop a unified approach to human brain banking covering a range of human brain disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio Scotland interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9CCB971A-1620-4BBB-9C59-E8B1AF9FEA95</gtr:id><gtr:impact>Radio interview as part of a panel discussing the ethics of brain donation for biomedical research</gtr:impact><gtr:outcomeId>58b319cdd44dd5.84047129</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Maximising the value of MRC Brain Banks: high-throughput genomic studies to enrich data available to the research community</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_13044</gtr:fundingRef><gtr:id>C1370A9D-3893-41AE-B7FF-7FB84B436D5C</gtr:id><gtr:outcomeId>58b3194d6d6107.19533024</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>This is a national brain bank database allowing neuroscience researchers an east access point to assess availability of human brain tissues throughout the UK</gtr:description><gtr:id>2F58BE68-D3F1-4C38-897A-9943283F20B4</gtr:id><gtr:impact>Standardised approach to basic neuropathological data stored across UK Brain Bank Network</gtr:impact><gtr:outcomeId>56c7382548ef18.66294448</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MRC Brain Bank database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>https://brainbanknetwork.cse.bris.ac.uk</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ABC0DAEC-3309-4001-BCF2-9BAE91075003</gtr:id><gtr:title>A case of variably protease-sensitive prionopathy treated with doxycyclin.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd73d19d7892a165f5a4cde0b5b81a6b"><gtr:id>fd73d19d7892a165f5a4cde0b5b81a6b</gtr:id><gtr:otherNames>Assar H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58b317cd76db51.71502698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>714949C1-F6AB-49BD-A732-062A4B5CB7E6</gtr:id><gtr:title>Novel genetic loci associated with hippocampal volume.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ef1639d3dafba8a52010bd7ff024e81"><gtr:id>1ef1639d3dafba8a52010bd7ff024e81</gtr:id><gtr:otherNames>Hibar DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa25125b91910.15191182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F54B48D3-CE0B-4CA5-A754-695B4CA6E2B9</gtr:id><gtr:title>Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/263cc3f9f1dd9c27a0280cdc0f5ba221"><gtr:id>263cc3f9f1dd9c27a0280cdc0f5ba221</gtr:id><gtr:otherNames>Henstridge CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa251248d7fb0.29869255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>110CB943-ECEA-41CC-875C-2BE0B0339B8D</gtr:id><gtr:title>The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58b317ccc217c6.22860849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEF26B71-EDD8-48CC-80EF-4730A8AE7749</gtr:id><gtr:title>Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>545785e37f0d01.24618325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>226E81F9-0943-4CE5-870A-D89AD033EA11</gtr:id><gtr:title>-glycosylation and expression in human tissues of the orphan GPR61 receptor.</gtr:title><gtr:parentPublicationTitle>FEBS open bio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fcd3f0052e649cbd5d4366cbcd90f8c"><gtr:id>2fcd3f0052e649cbd5d4366cbcd90f8c</gtr:id><gtr:otherNames>Kozielewicz P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2211-5463</gtr:issn><gtr:outcomeId>5aa251b95d6b12.13474695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F73D2B46-1769-474F-A5EE-FC4F862336CE</gtr:id><gtr:title>Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>doi_55f945945610ea4d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52F1F9E2-B12E-4C1E-ADD0-EA30926F21C6</gtr:id><gtr:title>Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa251258ccbd8.38876582</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4589FDB2-A703-4569-8037-8AB607C3BEB9</gtr:id><gtr:title>Differential gene expression in multiple neurological, inflammatory and connective tissue pathways in a spontaneous model of human small vessel stroke.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/071319bb8623a0326db801fa544aee1d"><gtr:id>071319bb8623a0326db801fa544aee1d</gtr:id><gtr:otherNames>Bailey EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5437bc92d3bea5.29242295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6EB44F-0BF5-4F2B-9EBA-4D4BC3688B30</gtr:id><gtr:title>Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01055eac7e580fc544e2d1e4189a8af6"><gtr:id>01055eac7e580fc544e2d1e4189a8af6</gtr:id><gtr:otherNames>Head MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12427_27_23550113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2CFFBC9-CA87-44F1-BBE2-56482788E85E</gtr:id><gtr:title>BrainNet Europe's Code of Conduct for brain banking.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a778ae923e3e5595466e2c6c6fceb07"><gtr:id>7a778ae923e3e5595466e2c6c6fceb07</gtr:id><gtr:otherNames>Klioueva NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58b317cd4bbe56.75335766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88FA9C92-527D-4708-B494-7C80DBD7B69D</gtr:id><gtr:title>Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12427_27_23967090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65D84C86-29FB-4105-90C1-D85784C9625C</gtr:id><gtr:title>UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa251ba5b6d16.25563994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25CB43DC-38B1-44F1-A7B9-9291BBEE7740</gtr:id><gtr:title>Post-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapse.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/263cc3f9f1dd9c27a0280cdc0f5ba221"><gtr:id>263cc3f9f1dd9c27a0280cdc0f5ba221</gtr:id><gtr:otherNames>Henstridge CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56c7321a3db560.02660638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F09D5AA-4792-4B81-9622-97F6075A41C9</gtr:id><gtr:title>Gerstmann-Stra&amp;uuml;ssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f960dc64663392005f3fbcba53da956"><gtr:id>9f960dc64663392005f3fbcba53da956</gtr:id><gtr:otherNames>Jones M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58b317ce66d899.30638482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B05543C4-D58E-4A9E-914E-80854E0EF8B1</gtr:id><gtr:title>Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ae1aa01433ba23d09fb7de58f533706"><gtr:id>7ae1aa01433ba23d09fb7de58f533706</gtr:id><gtr:otherNames>Newman PK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>doi_55f9459452d541c6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FB5FFA7-64D9-4B2E-A439-60D4591A1063</gtr:id><gtr:title>Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f12ee00bb95ee90e98f1b148708a7684"><gtr:id>f12ee00bb95ee90e98f1b148708a7684</gtr:id><gtr:otherNames>Skrobot OA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa251bb0d0a30.95977496</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4D3A653-500C-4AC7-9469-3AC7329397D6</gtr:id><gtr:title>The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.</gtr:title><gtr:parentPublicationTitle>Brain imaging and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545bcb850f5bee6c4b4bb77b4df4cf03"><gtr:id>545bcb850f5bee6c4b4bb77b4df4cf03</gtr:id><gtr:otherNames>Thompson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-7557</gtr:issn><gtr:outcomeId>545785e3a6af35.82330049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBA7B937-DD9D-46C5-A152-6014D08C3629</gtr:id><gtr:title>Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin.</gtr:title><gtr:parentPublicationTitle>Transfusion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc4c58d9e84539274a9200be96bf52cd"><gtr:id>dc4c58d9e84539274a9200be96bf52cd</gtr:id><gtr:otherNames>Oshita M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0041-1132</gtr:issn><gtr:outcomeId>58b317ccec6e50.00379326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>503C0199-5291-4E30-86A3-55DE55F7B0DB</gtr:id><gtr:title>Variant CJD. 18 years of research and surveillance.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>58b317cd9940c1.13026691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C33307C-5873-4100-9DAA-261265D73990</gtr:id><gtr:title>Widespread sex differences in gene expression and splicing in the adult human brain.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>545785e401a501.94488124</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E351F5D-2807-4BB1-8281-5A1B0D7D4645</gtr:id><gtr:title>The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58b317cde3b285.59848144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AA05090-5695-4757-9A6F-17B9B7C3D924</gtr:id><gtr:title>Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545785e3cdc959.16763452</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6064201-D806-4F9B-A38B-D4014896E073</gtr:id><gtr:title>Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c1fc934b985e758bb1c8ed68a940aae"><gtr:id>5c1fc934b985e758bb1c8ed68a940aae</gtr:id><gtr:otherNames>Alafuzoff I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>58b317ce3ba733.09064445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A836E9-FC13-4374-A2FD-521086F41692</gtr:id><gtr:title>Genome-wide association analysis identifies six new loci associated with forced vital capacity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/709f22fc76ef5afc571a9a040d0788d6"><gtr:id>709f22fc76ef5afc571a9a040d0788d6</gtr:id><gtr:otherNames>Loth DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545785e3566e52.69597236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>974818D0-D66F-411F-B81A-3A9E59F2F900</gtr:id><gtr:title>Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/753428add4471d7010ecfa8b2c26dd3a"><gtr:id>753428add4471d7010ecfa8b2c26dd3a</gtr:id><gtr:otherNames>Manousopoulou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>5aa251263fa827.88989736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5BBE052-7255-42E4-9FC3-2CEC3546C1B8</gtr:id><gtr:title>Deposition of amyloid ? in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6064a4d07cab171f38b6cdd1227ad29"><gtr:id>e6064a4d07cab171f38b6cdd1227ad29</gtr:id><gtr:otherNames>Keable A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>5aa2512668cec4.57394161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEC5B94E-6875-418A-999F-89F19F9CD1A0</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>545785e3305356.75977288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A0CEAC7-1576-4303-B6BD-23AA488C1120</gtr:id><gtr:title>Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d54e0f74c95125e20ee2238719dac20"><gtr:id>3d54e0f74c95125e20ee2238719dac20</gtr:id><gtr:otherNames>Douet JY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5aa251ba06d014.37399037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>320AB842-96C5-4FC0-99E1-711AE1860503</gtr:id><gtr:title>Analysis of the prion protein gene in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58b317cc4189d2.27503369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD329DA6-322B-4D95-92F9-DB3A1B4B7D53</gtr:id><gtr:title>Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a439e3cead6e102b8a7c8e439170b4fb"><gtr:id>a439e3cead6e102b8a7c8e439170b4fb</gtr:id><gtr:otherNames>Wei W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>58b317cbe72994.53132442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDF943F2-DEF0-49F5-8DD3-4EAEA8846329</gtr:id><gtr:title>Activin receptors regulate the oligodendrocyte lineage in health and disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f0176facdae851ec69c74f17f9bce60"><gtr:id>7f0176facdae851ec69c74f17f9bce60</gtr:id><gtr:otherNames>Dillenburg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa25124eb5520.02544022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>749BE4E7-FE2E-44E8-A4B1-D1EC7050069F</gtr:id><gtr:title>The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2ca9145f48adcb73e0b6ea59d85fe7"><gtr:id>af2ca9145f48adcb73e0b6ea59d85fe7</gtr:id><gtr:otherNames>Wiseman FK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58b317cd2478e7.32992788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ACC6405-D300-4E6D-B07E-AC3EEA14D890</gtr:id><gtr:title>Comparative Study of Prions in Iatrogenic and Sporadic Creutzfeldt-Jakob Disease.</gtr:title><gtr:parentPublicationTitle>Journal of clinical &amp; cellular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc8dc855a7c01c5ac3178caa93b7b86b"><gtr:id>dc8dc855a7c01c5ac3178caa93b7b86b</gtr:id><gtr:otherNames>Xiao X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>58b317cdc09177.60370723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CC2DFCC-D9F1-4DA5-B9C9-8337CA04E485</gtr:id><gtr:title>MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e98df31dd286214d8b1f0848de310ad0"><gtr:id>e98df31dd286214d8b1f0848de310ad0</gtr:id><gtr:otherNames>Petrovic IN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_12427_27_23180183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C9DFDEB-8ADF-47C1-9B69-D6EEA65DD626</gtr:id><gtr:title>Age-associated changes in gene expression in human brain and isolated neurons.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a93647d799d53d5111001b3b241fdab"><gtr:id>1a93647d799d53d5111001b3b241fdab</gtr:id><gtr:otherNames>Kumar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12427_27_23177596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2F5FD5E-B16F-4BE1-9CE7-C3FCC11C4527</gtr:id><gtr:title>Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/014f62366555b270d7daae3cc0c9f4da"><gtr:id>014f62366555b270d7daae3cc0c9f4da</gtr:id><gtr:otherNames>Keogh MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>58b317cc1b9a76.44921362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A735D60-E752-4113-8612-2E1A87441367</gtr:id><gtr:title>Similarities of Variant Creutzfeldt-Jakob Disease Strain in Mother and Son in Spain to UK Reference Case.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06d2584ebbcc5853cd21c01b4c7378c8"><gtr:id>06d2584ebbcc5853cd21c01b4c7378c8</gtr:id><gtr:otherNames>Diack AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>5a31d87cd015a8.92038504</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C73CD7-A7DE-4C91-BDF1-6951EEAD3A09</gtr:id><gtr:title>Clusterin protects neurons against intracellular proteotoxicity.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1af6a7aa2b6eb07c70cf4f56e724f4c1"><gtr:id>1af6a7aa2b6eb07c70cf4f56e724f4c1</gtr:id><gtr:otherNames>Gregory JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5aa251253db956.77606718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D18B28D-1E94-4D29-B122-2B6C77EB0664</gtr:id><gtr:title>Genetic variability in the regulation of gene expression in ten regions of the human brain.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>545785e305ad18.20600423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD4106B6-DC29-4609-AA10-8782DA625473</gtr:id><gtr:title>Brain banking for neurological disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_12427_27_24074724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6D98EEC-2E2A-4638-833B-2615D3C7269A</gtr:id><gtr:title>C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca-permeable AMPA receptor-mediated excitotoxicity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96d4ab24d1215f7ba80c2957f9f78cf3"><gtr:id>96d4ab24d1215f7ba80c2957f9f78cf3</gtr:id><gtr:otherNames>Selvaraj BT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aa24f3e611152.70592765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E857EC02-4509-4DE8-916C-72824E784AD7</gtr:id><gtr:title>Sporadic and Infectious Human Prion Diseases.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5cc148a1af756621f53e2c335b8d343"><gtr:id>c5cc148a1af756621f53e2c335b8d343</gtr:id><gtr:otherNames>Will RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>58b317cc64ea63.05741558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6F1729C-B636-4D7B-98BE-D7A147F64E55</gtr:id><gtr:title>Insights into TREM2 biology by network analysis of human brain gene expression data.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05229e5e9f0a501fa7e63a396d570040"><gtr:id>05229e5e9f0a501fa7e63a396d570040</gtr:id><gtr:otherNames>Forabosco P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_12427_27_23855984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21321C60-BB02-4272-BFD5-1DB8D163B1DE</gtr:id><gtr:title>Neuropathology of Human Prion Diseases.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>5aa251b9bb7437.01620147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B060FF44-5BED-44F4-B430-6FDA08C2EA9F</gtr:id><gtr:title>Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>585d54eae87ab7.43314894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7C41FA-C629-40EA-8DA0-57BCFE6C866A</gtr:id><gtr:title>Hemoglobin mRNA Changes in the Frontal Cortex of Patients with Neurodegenerative Diseases.</gtr:title><gtr:parentPublicationTitle>Frontiers in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cdb00a3df43e8f580a15e4469167a51"><gtr:id>0cdb00a3df43e8f580a15e4469167a51</gtr:id><gtr:otherNames>Vanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1662-453X</gtr:issn><gtr:outcomeId>5aa251b9249d07.27312245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11FF3DC8-9486-4C73-82F2-4743311B37D1</gtr:id><gtr:title>Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07240e0b568fffe6666802d85e6ad710"><gtr:id>07240e0b568fffe6666802d85e6ad710</gtr:id><gtr:otherNames>Pettit LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12427_27_24056536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4AFFB9B-1984-41BC-B880-FD43AF23E7BD</gtr:id><gtr:title>Investigation of variant Creutzfeldt-Jakob disease implicated organ or tissue transplantation in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0c4e3b3cd3b5715bd3fc2e4295b75b6"><gtr:id>f0c4e3b3cd3b5715bd3fc2e4295b75b6</gtr:id><gtr:otherNames>Molesworth A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0041-1337</gtr:issn><gtr:outcomeId>58b317ce8e8ed7.21857982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34E93E22-F6ED-46B5-A9E7-3BE736631AD3</gtr:id><gtr:title>Synaptic phosphorylated a-synuclein in dementia with Lewy bodies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f20fdef9cf1522dc7f385f429e386a7"><gtr:id>3f20fdef9cf1522dc7f385f429e386a7</gtr:id><gtr:otherNames>Colom-Cadena M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa25124c104d7.63480520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4296380D-E0BA-4E32-A056-98F755BA7469</gtr:id><gtr:title>Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/855c4a089ec5c5e7721a1cfcd947afe6"><gtr:id>855c4a089ec5c5e7721a1cfcd947afe6</gtr:id><gtr:otherNames>Graham LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>5aa251256b13c3.09404616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E2AEF28-9B82-4956-A775-DED04360293C</gtr:id><gtr:title>Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a171f3d658cd96b7ebe3bcec8dea503c"><gtr:id>a171f3d658cd96b7ebe3bcec8dea503c</gtr:id><gtr:otherNames>Soreq L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58b3164539db10.67121555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF6323A-E720-4E5A-B6CC-A8C73FA57ECC</gtr:id><gtr:title>Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec0a71e748a31537ac2f92252f176a33"><gtr:id>ec0a71e748a31537ac2f92252f176a33</gtr:id><gtr:otherNames>Franke B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56c7321960af49.37669338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE3045E5-6A68-460E-8C47-6D122B645813</gtr:id><gtr:title>Novel genetic loci underlying human intracranial volume identified through genome-wide association.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e2661c4e36c54a85ad324bac655b6bf"><gtr:id>6e2661c4e36c54a85ad324bac655b6bf</gtr:id><gtr:otherNames>Adams HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>5aa25126028e80.88908982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7C465B2-B1A7-45A5-BB51-6433828B5867</gtr:id><gtr:title>Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studies.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_12427_27_23435227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EDC814B-6E79-4693-9130-0D758FD7B23E</gtr:id><gtr:title>Common genetic variants influence human subcortical brain structures.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ef1639d3dafba8a52010bd7ff024e81"><gtr:id>1ef1639d3dafba8a52010bd7ff024e81</gtr:id><gtr:otherNames>Hibar DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56c73219168c01.91573939</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF9FD128-3F19-4132-AE38-3EC48A04FBC4</gtr:id><gtr:title>Studying synapses in human brain with array tomography and electron microscopy.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e76a03e1194b13409cb1ca79bf9fc71"><gtr:id>4e76a03e1194b13409cb1ca79bf9fc71</gtr:id><gtr:otherNames>Kay KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_12427_27_23787894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BA3B23C-5B67-46AE-88C2-C748F1CC2DAE</gtr:id><gtr:title>Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be30e536c69b9bcb232a510dc483d354"><gtr:id>be30e536c69b9bcb232a510dc483d354</gtr:id><gtr:otherNames>Bishop MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_12427_27_23449776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CB3AA13-A9B0-4C61-A95E-2D80CBF569B6</gtr:id><gtr:title>Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0224a5b82887b2ff861c7e49a8edd715"><gtr:id>0224a5b82887b2ff861c7e49a8edd715</gtr:id><gtr:otherNames>Choi YP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>58b317ce178b02.87404933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>178A3D3C-9D70-45E3-8F13-707B82001ADC</gtr:id><gtr:title>Amyloid-? accumulation in the CNS in human growth hormone recipients in the UK.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f136b5c6a6d4c119e384c1fd2f48b4c9"><gtr:id>f136b5c6a6d4c119e384c1fd2f48b4c9</gtr:id><gtr:otherNames>Ritchie DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>5aa251ba30e3f6.44180595</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03357A37-16E9-42F4-B0BE-28CCE5F4A5AC</gtr:id><gtr:title>Proteomic analysis of postsynaptic proteins in regions of the human neocortex.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8981c4f2070525c103dc2a8b381da5d"><gtr:id>a8981c4f2070525c103dc2a8b381da5d</gtr:id><gtr:otherNames>Roy M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>5aa251251c9e70.22020940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A65CEAA-E891-4844-8D3D-65B548DEA416</gtr:id><gtr:title>Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1bc530dea0f047a0508cb343a8ec2de"><gtr:id>c1bc530dea0f047a0508cb343a8ec2de</gtr:id><gtr:otherNames>Kasperaviciute D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e17be17b7aa57b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC55F4C0-85C0-44F9-8D50-4878078E7439</gtr:id><gtr:title>Relative Abundance of apoE and A?1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48df2869b0ba296c7ba8136a5487142b"><gtr:id>48df2869b0ba296c7ba8136a5487142b</gtr:id><gtr:otherNames>Moore RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>58b317cc9d5b03.39881101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C540544-D882-4AD6-B589-E855DD4FDAA3</gtr:id><gtr:title>Differential overexpression of SERPINA3 in human prion diseases.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cdb00a3df43e8f580a15e4469167a51"><gtr:id>0cdb00a3df43e8f580a15e4469167a51</gtr:id><gtr:otherNames>Vanni S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa251b98a5265.73925678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FF51BA0-91A1-4D42-A452-03A4AA1BFE38</gtr:id><gtr:title>Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56c7321a6fdf25.49247711</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L016400/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>